Study To Evaluate Safety, Tolerability, And Pharmacokinetics Of PF-06473871 In Normal Healthy Adults

NCT01753791 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: 80 mg PF-06473871
DRUG: 160 mg PF-06473871
DRUG: 320 mg PF-06473871
DRUG: 480 mg PF-06473871

Sponsor

Pfizer